Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1953 1
1955 2
1958 4
1961 2
1962 3
1963 3
1964 8
1965 4
1966 3
1968 4
1969 1
1970 4
1971 6
1972 6
1973 6
1974 1
1975 2
1976 3
1977 9
1979 4
1980 4
1981 17
1982 3
1983 8
1984 9
1985 16
1986 20
1987 22
1988 23
1989 72
1990 39
1991 31
1992 39
1993 49
1994 49
1995 71
1996 95
1997 83
1998 94
1999 109
2000 125
2001 166
2002 223
2003 238
2004 328
2005 395
2006 465
2007 554
2008 720
2009 800
2010 926
2011 1181
2012 1395
2013 1599
2014 1838
2015 2187
2016 2354
2017 2672
2018 3162
2019 3646
2020 4169
2021 4734
2022 5699
2023 5419
2024 2795

Text availability

Article attribute

Article type

Publication date

Search Results

43,374 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Hsi-Yu
Page 1
Did you mean shi yu niu (27 results)?
Adalimumab in the treatment of non-infectious uveitis.
Burek-Michalska A, Turno-Kręcicka A. Burek-Michalska A, et al. Adv Clin Exp Med. 2020 Oct;29(10):1231-1236. doi: 10.17219/acem/125431. Adv Clin Exp Med. 2020. PMID: 33125196 Free article. Review.
Non-infectious uveitis (NIU) is a serious sight-threatening condition whose pathogenesis is often autoimmune in nature. ...It can occur only in the eye or as a symptom of a systemic condition. The most common cause of NIU is HLA-B-27-associated anterior uveitis (4-3 …
Non-infectious uveitis (NIU) is a serious sight-threatening condition whose pathogenesis is often autoimmune in nature. ...It can occ …
New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
Rosenbaum JT, Bodaghi B, Couto C, Zierhut M, Acharya N, Pavesio C, Tay-Kearney ML, Neri P, Douglas K, Pathai S, Song AP, Kron M, Foster CS. Rosenbaum JT, et al. Semin Arthritis Rheum. 2019 Dec;49(3):438-445. doi: 10.1016/j.semarthrit.2019.06.004. Epub 2019 Jun 10. Semin Arthritis Rheum. 2019. PMID: 31301816 Free article. Review.
NIU is one of the leading causes of preventable blindness. OBJECTIVE: This review describes current and emerging therapies for NIU. ...CONCLUSION: Biologics, JAK/STAT inhibitors, and improved localized therapies may provide additional options for patients with NI
NIU is one of the leading causes of preventable blindness. OBJECTIVE: This review describes current and emerging therapies for NIU
JAK-STAT signaling pathway in non-infectious uveitis.
Su Y, Tao T, Liu X, Su W. Su Y, et al. Biochem Pharmacol. 2022 Oct;204:115236. doi: 10.1016/j.bcp.2022.115236. Epub 2022 Aug 27. Biochem Pharmacol. 2022. PMID: 36041544 Review.
Non-infectious uveitis (NIU) refers to various intraocular inflammatory disorders responsible for severe visual loss. ...Increasing evidence from human NIU and experimental models reveals the involvement of the JAK-STAT signaling pathway in NIU pathogenesis. …
Non-infectious uveitis (NIU) refers to various intraocular inflammatory disorders responsible for severe visual loss. ...Increasing e …
Biotherapies in Uveitis.
Leclercq M, Desbois AC, Domont F, Maalouf G, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Leclercq M, et al. J Clin Med. 2020 Nov 8;9(11):3599. doi: 10.3390/jcm9113599. J Clin Med. 2020. PMID: 33171664 Free PMC article. Review.
Non-infectious uveitis (NIU) represents one of the leading causes of blindness in developed countries. ...The objective of this review is to present an updated overview of knowledge on the use of biological treatments in NIU....
Non-infectious uveitis (NIU) represents one of the leading causes of blindness in developed countries. ...The objective of this revie …
Microbiome in Immune-Mediated Uveitis.
Rodríguez-Fernández CA, Iglesias MB, de Domingo B, Conde-Pérez K, Vallejo JA, Rodríguez-Martínez L, González-Barcia M, Llorenç V, Mondelo-Garcia C, Poza M, Fernández-Ferreiro A. Rodríguez-Fernández CA, et al. Int J Mol Sci. 2022 Jun 24;23(13):7020. doi: 10.3390/ijms23137020. Int J Mol Sci. 2022. PMID: 35806031 Free PMC article. Review.
The gut microbiome plays an important role in controlling immune response, and dysbiosis has been associated with immune-mediated diseases such as non-infectious uveitis (NIU). In this review, we gather the published evidence, both in the pre-clinical and clinical studies, …
The gut microbiome plays an important role in controlling immune response, and dysbiosis has been associated with immune-mediated diseases s …
Generalized tetanus.
Niu KY, Lin YK. Niu KY, et al. CMAJ. 2019 Aug 26;191(34):E944. doi: 10.1503/cmaj.190161. CMAJ. 2019. PMID: 31451526 Free PMC article. No abstract available.
Physicians' Electrocardiogram Interpretations.
He M, Deng X, Niu W. He M, et al. JAMA Intern Med. 2021 May 1;181(5):721-722. doi: 10.1001/jamainternmed.2020.8605. JAMA Intern Med. 2021. PMID: 33523117 No abstract available.
Intraocular therapy in noninfectious uveitis.
Modugno RL, Testi I, Pavesio C. Modugno RL, et al. J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. doi: 10.1186/s12348-021-00267-x. J Ophthalmic Inflamm Infect. 2021. PMID: 34632541 Free PMC article. Review.
Systemic corticosteroids and immunosuppressant agents are the mainstay of therapy for non-infectious uveitis (NIU). However, the risks associated with systemic administration and the need of delivering an effective and safe anti-inflammatory treatment targeted to the site …
Systemic corticosteroids and immunosuppressant agents are the mainstay of therapy for non-infectious uveitis (NIU). However, the risk …
43,374 results
You have reached the last available page of results. Please see the User Guide for more information.